BBOT
BridgeBio Oncology
BBOT
BBOT
42 hedge funds and large institutions have $658M invested in BridgeBio Oncology in 2025 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
24% more funds holding
Funds holding: 34 → 42 (+8)
16.67% less ownership
Funds ownership: 88.41% → 71.74% (-17%)
Holders
42
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$173M | |
| 2 | +$56.6M | |
| 3 | +$38.1M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
+$32.7M |
| 5 |
AI
Alphabet Inc
Mountain View,
California
|
+$32.7M |
Top Sellers
| 1 | -$8.5M | |
| 2 | -$6.39M | |
| 3 | -$6.05M | |
| 4 |
Millennium Management
New York
|
-$5.79M |
| 5 |
WRBC
W.R. Berkley Corp
Greenwich,
Connecticut
|
-$4.73M |
